CP
SWAV

Castleview Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Castleview Partners’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-230
Closed -$64K – 716
2022
Q3 		$64K Buy
+230
New +$58.5K 0.06% 217

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Castleview Partners's SWAV Position: Q4 2022 in Review

Castleview Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 230 shares — an estimated $64K sold.

Castleview Partners first reported a position in SWAV in Q3 2022 and held it in 1 quarter. The position peaked at $64K in Q3 2022. 415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

  • Castleview Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Castleview Partners sold 230 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $64K.
  • Castleview Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Castleview Partners's Shockwave Medical, Inc. Common Stock position peaked at $64K in Q3 2022.
  • 415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on Castleview Partners's 13F filing for Q4 2022, filed 1 Feb 2023.